On Track for Best Ever Financial Performance

Guildford, UK, and Burlington, Mass. – IDBS, the leading worldwide provider of data management and analytics solutions to R&D and healthcare organizations, announces that, as the result of continuing expansion, and growth in demand for its products and services, revenues for the six months ended June 30, 2010 rose by 20% on the same period of 2009 to $20.3 million, with profit before tax also growing strongly.

These results follow the excellent progress made in 2009, for which IDBS reported 12% revenue growth to $36.4 million, with the company sustaining healthy underlying profitability and margins and completing the cash acquisition of InforSense in June 2009.

Excluding the impact of InforSense, underlying revenue growth was well into double digits, with underlying profit before tax significantly up on the first half of last year. This reflects growing and recurring revenues from existing customers as well as projects completed for new customers.

Revenue for the first half of 2010 benefited from a strong product performance in the company’s core pharmaceuticals market where organizations are seeking to improve the effectiveness of their business processes and the use of high-value data. Key to growth for the period was the implementation of significant projects, involving the E-WorkBook Suite, at a number of major companies for drug formulation and preclinical development, and at a contract manufacturer of biologics for process development improvement.

Software sales for the period grew by 44% on the first half of 2009, with maintenance revenues increasing by 13% and professional services by 25%.

Since the acquisition of InforSense, IDBS has established a leading position in the high-growth market of biomarker and personalized medicine research, recently winning a number of new contracts which will benefit the second half of 2010 and beyond. These include a significant engagement with Barts Hospital and The London NHS Trust to improve the understanding of cardiovascular disease in the UK.

“R&D companies and healthcare organizations recognize the strategic value of IDBS in process improvement projects, enhancing regulatory compliance and research collaboration,” said Neil Kipling, founder and CEO of IDBS. “Our reputation and market leadership are based on our data management expertise and solutions combined with an unrivalled understanding of scientists, the R&D process and the needs of our customers. We are continuing to invest in the business and to strengthen our relationships with existing and new customers. As a result, we are confident that IDBS is on track to achieve its best ever financial performance in 2010 and to continue to make strong progress thereafter.”

During the period, IDBS was included in the 2010 ProfitTrack100 list of private companies, recognizing the company’s long-term record of sustained, profitable growth.

About IDBS

IDBS is a unique, global supplier of innovative data management and analytics solutions, which increase efficiency, reduce costs and improve business and scientific productivity of R&D organizations worldwide. Organizations such as Pfizer, GSK, Celera, MedImmune, Dana-Farber, and Roche employ IDBS solutions as an integral part of their strategy to address the increasing pressures placed upon them by the need for the secure, compliant capture, integration and analysis of complex research data. IDBS is clearly differentiated from other software providers by its unique combination of deep domain knowledge and its ability to rapidly provide integrated business process and robust data analytics solutions along the entire R&D value chain. IDBS solutions secure organizations’ valuable R&D data assets and enable rapid decision-making through effective integration and analysis. They also support the protection of Intellectual Property (IP) and the requirements for data quality demanded under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.

IDBS is a private company, founded in 1989 and headquartered in Guildford, UK. IDBS has worldwide consulting and support presence, with U.S. offices in California, New Jersey and Massachusetts, the EU, Australia and China.